This 17 page paper examines the case of Genesis Research and Development Corporation; a biotechnology research and development company based in New Zealand which has not developed a commercial product. The company is examined with the use of a PEST, SWOT and Ports Five Forces framework, the reasons why the company may be valued at a low level by investors and advice is then given to the new CEO regarding two potential strategies that will support firm. The paper is based on a case study provided by the student. The bibliography cites 5 sources.
Name of Research Paper File: TS14_TEgenesis2.rtf
Unformatted Sample Text from the Research Paper:
a product that has been brought to market. In order to consider the position of the organization utilization of a PEST and SWOT analysis will provide a useful framework to
assess the organization within its environment. 1.1 PEST Analysis There are a large number of macro environmental influences in any industry. A PEST analysis looks at the political, economic, social
and technological influences. The political influences a highly influential with the New Zealand. For any industry to develop and grow it needs a suitable environment, where is development is supported
and nurtured. This it appears to be an aspect which is missing with in the New Zealand biotechnology environment, Greg Lucier, head of Invitrogen, one of the worlds largest biotechnology
companies is argued that New Zealands position within the biotechnology research and development segment is being severely hampered as a result of government policy, both in terms of the lack
of investment and industries receiving, as well as the contradictory stance that the government is adopting towards genetic engineering. New Zealand has a great deal reliance on agricultural markets, but
it is also a culture where there is a greater suspicion regarding genetic modification, both internally, and as a result of its this reliance on trade in international environment when
it introduced a moratorium on the release of genetically modified crops 1999, it was undertaking political moves in reaction to both the internal and the global fears regarding genetically modified
crops. This places a significant constraint on New Zealand biotechnology companies. However, this is not mean the New Zealand government is giving the biotechnology industries no support, although the agricultural
side of the industry is having significant difficulties as a result of the stance on genetically modified crops, which has a knock on effect to other biotechnology developments within the